Skip to main content
Top
Published in: Journal of General Internal Medicine 10/2016

01-10-2016 | Original Research

Assessing Problematic Substance Use in HIV Care: Which Questions Elicit Accurate Patient Disclosures?

Authors: Wynne Callon, BA, Mary Catherine Beach, MD, MPH, Somnath Saha, MD, MPH, Geetanjali Chander, MD, MPH, Ira B. Wilson, MD, Michael Barton Laws, PhD, Victoria Sharp, MD, Jonathan Cohn, MD, Richard Moore, MD, MHS, P. Todd Korthuis, MD, MPH

Published in: Journal of General Internal Medicine | Issue 10/2016

Login to get access

ABSTRACT

BACKGROUND

Substance use is associated with higher rates of antiretroviral non-adherence and poor HIV outcomes. This study examined how HIV care providers assess substance use, and which questions elicit accurate patient disclosures.

METHODS

We conducted a conversation analysis of audio-recorded encounters between 56 providers and 162 patients living with HIV (PLWH) reporting active substance use in post-encounter interviews (cocaine or heroin use in the past 30 days, > 4 days intoxicated in past 30 days, or AUDIT score ≥ 8). We assessed the frequency of substance use discussion, characterized the types of questions used by providers, and determined the frequency of accurate patient disclosure by question type.

RESULTS

In 55 reports of active substance use, providers already knew about the use (n = 16) or patients disclosed unpromptednn = 39). Among the remaining 155 instances of substance use in which providers had the opportunity to elicit disclosure, 78 reports (50 %) of substance use were not discussed. Of the remaining 77 reports in which the provider asked about substance use, 55 (71 %) patients disclosed and 22 (29 %) did not disclose. Questions were classified as: open-ended (n = 18, “How’s the drinking going?”); normalizing (n = 14, “When was the last time you used?”); closed-ended (n = 36, “Have you used any cocaine?”); leading towards non-use (n = 9, “Have you been clean?”). Accurate disclosure followed 100 % of open-ended and normalizing questions, 58 % of closed-ended questions, and 22 % of leading questions. After adjusting for drug type, closed-ended questions were 41 % less likely (p < 0.001), and ‘leading’ questions 78 % less likely (p = 0.016) than broad and normalizing questions to elicit disclosures.

CONCLUSION

Providers in this sample missed almost half of the opportunities to identify and discuss substance use with PLWH. Providers can increase the probability of patient disclosure by using open-ended or normalizing questions that ask about the “last time” that the patient used drugs or alcohol.
Literature
2.
go back to reference Nath A, Hauser KF, Wojna V, Booze RM, Maragos W, Prendergast M, et al. Molecular basis for interactions of HIV and drugs of abuse. J Acquir Immune Defic Syndr 1999. 2002;31(Suppl 2):S62–9.CrossRef Nath A, Hauser KF, Wojna V, Booze RM, Maragos W, Prendergast M, et al. Molecular basis for interactions of HIV and drugs of abuse. J Acquir Immune Defic Syndr 1999. 2002;31(Suppl 2):S62–9.CrossRef
3.
go back to reference Chander G, Lau B, Moore RD.Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection. J Acquir Immune Defic Syndr 1999. 2006;43(4):411–7.CrossRef Chander G, Lau B, Moore RD.Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection. J Acquir Immune Defic Syndr 1999. 2006;43(4):411–7.CrossRef
4.
go back to reference Miguez MJ, Shor-Posner G, Morales G, Rodriguez A, Burbano X. HIV treatment in drug abusers: impact of alcohol use. Addict Biol. 2003;8(1):33–7.CrossRefPubMed Miguez MJ, Shor-Posner G, Morales G, Rodriguez A, Burbano X. HIV treatment in drug abusers: impact of alcohol use. Addict Biol. 2003;8(1):33–7.CrossRefPubMed
5.
go back to reference Lucas GM, Gebo KA, Chaisson RE, Moore RD. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS Lond Engl. 2002;16(5):767–74.CrossRef Lucas GM, Gebo KA, Chaisson RE, Moore RD. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS Lond Engl. 2002;16(5):767–74.CrossRef
6.
go back to reference Chander G, Himelhoch S, Moore RD. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy. Drugs. 2006;66(6):769–89.CrossRefPubMed Chander G, Himelhoch S, Moore RD. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy. Drugs. 2006;66(6):769–89.CrossRefPubMed
7.
go back to reference Lucas GM, Griswold M, Gebo KA, Keruly J, Chaisson RE, Moore RD. Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy. Am J Epidemiol. 2006;163(5):412–20.CrossRefPubMed Lucas GM, Griswold M, Gebo KA, Keruly J, Chaisson RE, Moore RD. Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy. Am J Epidemiol. 2006;163(5):412–20.CrossRefPubMed
8.
go back to reference Cohn SE, Jiang H, McCutchan JA, Koletar SL, Murphy RL, Robertson KR, et al. Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: results from ACTG 362. AIDS Care. 2011;23(6):775–85.CrossRefPubMedPubMedCentral Cohn SE, Jiang H, McCutchan JA, Koletar SL, Murphy RL, Robertson KR, et al. Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: results from ACTG 362. AIDS Care. 2011;23(6):775–85.CrossRefPubMedPubMedCentral
9.
go back to reference Cofrancesco J, Scherzer R, Tien PC, Gibert CL, Southwell H, Sidney S, et al. Illicit drug use and HIV treatment outcomes in a US cohort. AIDS Lond Engl. 2008;22(3):357–65.CrossRef Cofrancesco J, Scherzer R, Tien PC, Gibert CL, Southwell H, Sidney S, et al. Illicit drug use and HIV treatment outcomes in a US cohort. AIDS Lond Engl. 2008;22(3):357–65.CrossRef
10.
go back to reference Hinkin CH, Barclay TR, Castellon SA, Levine AJ, Durvasula RS, Marion SD, et al. Drug Use and Medication Adherence among HIV-1 Infected Individuals. AIDS Behav. 2006;11(2):185–94.CrossRef Hinkin CH, Barclay TR, Castellon SA, Levine AJ, Durvasula RS, Marion SD, et al. Drug Use and Medication Adherence among HIV-1 Infected Individuals. AIDS Behav. 2006;11(2):185–94.CrossRef
11.
go back to reference Hendershot CS, Stoner SA, Pantalone DW, Simoni JM. Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr 1999. 2009;52(2):180.CrossRef Hendershot CS, Stoner SA, Pantalone DW, Simoni JM. Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr 1999. 2009;52(2):180.CrossRef
12.
go back to reference Samet JH, Horton NJ, Meli S, Freedberg KA, Palepu A. Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcohol Clin Exp Res. 2004;28(4):572–7.CrossRefPubMed Samet JH, Horton NJ, Meli S, Freedberg KA, Palepu A. Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcohol Clin Exp Res. 2004;28(4):572–7.CrossRefPubMed
13.
go back to reference Arnsten JH, Demas PA, Grant RW, Gourevitch MN, Farzadegan H, Howard AA, et al. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med. 2002;17(5):377–81.CrossRefPubMedPubMedCentral Arnsten JH, Demas PA, Grant RW, Gourevitch MN, Farzadegan H, Howard AA, et al. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med. 2002;17(5):377–81.CrossRefPubMedPubMedCentral
14.
go back to reference Rosen MI, Black AC, Arnsten JH, Goggin K, Remien RH, Simoni JM, et al. Association between use of specific drugs and antiretroviral adherence: findings from MACH 14. AIDS Behav. 2013;17(1):142–7.CrossRefPubMedPubMedCentral Rosen MI, Black AC, Arnsten JH, Goggin K, Remien RH, Simoni JM, et al. Association between use of specific drugs and antiretroviral adherence: findings from MACH 14. AIDS Behav. 2013;17(1):142–7.CrossRefPubMedPubMedCentral
15.
go back to reference Bing EG, Burnam M, Longshore D, et al. Psychiatric disorders and drug use among human immunodeficiency virus–infected adults in the United States. Arch Gen Psychiatry. 2001;58(8):721–8.CrossRefPubMed Bing EG, Burnam M, Longshore D, et al. Psychiatric disorders and drug use among human immunodeficiency virus–infected adults in the United States. Arch Gen Psychiatry. 2001;58(8):721–8.CrossRefPubMed
16.
go back to reference TJ Cory PR. New Antiretroviral Therapies and Potential Drug Interactions in HIV Infected Drug Abusers. J Antivir Antiretrovir. 2014;06(03). TJ Cory PR. New Antiretroviral Therapies and Potential Drug Interactions in HIV Infected Drug Abusers. J Antivir Antiretrovir. 2014;06(03).
17.
go back to reference Kumar S, Rao P, Earla R, Kumar A. Drug–drug interactions between anti-retroviral therapies and drugs of abuse in HIV systems. Expert Opin Drug Metab Toxicol. 2014;11(3):343–55.CrossRefPubMedPubMedCentral Kumar S, Rao P, Earla R, Kumar A. Drug–drug interactions between anti-retroviral therapies and drugs of abuse in HIV systems. Expert Opin Drug Metab Toxicol. 2014;11(3):343–55.CrossRefPubMedPubMedCentral
18.
go back to reference Friedmann PD, McCullough D, Saitz R. Screening and intervention for illicit drug abuse: a national survey of primary care physicians and psychiatrists. Arch Intern Med. 2001;161(2):248–51.CrossRefPubMed Friedmann PD, McCullough D, Saitz R. Screening and intervention for illicit drug abuse: a national survey of primary care physicians and psychiatrists. Arch Intern Med. 2001;161(2):248–51.CrossRefPubMed
19.
go back to reference Hawkins EJ, Kivlahan DR, Williams EC, Wright SM, Craig T, Bradley KA. Examining quality issues in alcohol misuse screening. Subst Abuse. 2007;28(3):53–65.CrossRef Hawkins EJ, Kivlahan DR, Williams EC, Wright SM, Craig T, Bradley KA. Examining quality issues in alcohol misuse screening. Subst Abuse. 2007;28(3):53–65.CrossRef
20.
go back to reference Moriarty HJ, Stubbe MH, Chen L, Tester RM, Macdonald LM, Dowell AC, et al. Challenges to alcohol and other drug discussions in the general practice consultation. Fam Pract. 2012;29(2):213–22.CrossRefPubMed Moriarty HJ, Stubbe MH, Chen L, Tester RM, Macdonald LM, Dowell AC, et al. Challenges to alcohol and other drug discussions in the general practice consultation. Fam Pract. 2012;29(2):213–22.CrossRefPubMed
21.
go back to reference Korthuis PT, Josephs JS, Fleishman JA, Hellinger J, Himelhoch S, Chander G, et al. Substance abuse treatment in human immunodeficiency virus: the role of patient–provider discussions. J Subst Abuse Treat. 2008;35(3):294–303.CrossRefPubMedPubMedCentral Korthuis PT, Josephs JS, Fleishman JA, Hellinger J, Himelhoch S, Chander G, et al. Substance abuse treatment in human immunodeficiency virus: the role of patient–provider discussions. J Subst Abuse Treat. 2008;35(3):294–303.CrossRefPubMedPubMedCentral
22.
go back to reference McCormick KA, Cochran NE, Back AL, Merrill JO, Williams EC, Bradley KA. How primary care providers talk to patients about alcohol: a qualitative study. J Gen Intern Med. 2006;21(9):966–72.CrossRefPubMedPubMedCentral McCormick KA, Cochran NE, Back AL, Merrill JO, Williams EC, Bradley KA. How primary care providers talk to patients about alcohol: a qualitative study. J Gen Intern Med. 2006;21(9):966–72.CrossRefPubMedPubMedCentral
23.
go back to reference Beach MC, Saha S, Korthuis PT, Sharp V, Cohn J, Wilson IB, et al. Patient–provider communication differs for black compared to white HIV-infected patients. AIDS Behav. 2011;15(4):805–11.CrossRefPubMedPubMedCentral Beach MC, Saha S, Korthuis PT, Sharp V, Cohn J, Wilson IB, et al. Patient–provider communication differs for black compared to white HIV-infected patients. AIDS Behav. 2011;15(4):805–11.CrossRefPubMedPubMedCentral
24.
go back to reference Beach MC, Saha S, Korthuis PT, Sharp V, Cohn J, Wilson I, et al. Differences in patient–provider communication for Hispanic compared to non-Hispanic white patients in HIV care. J Gen Intern Med. 2010;25(7):682–7.CrossRefPubMedPubMedCentral Beach MC, Saha S, Korthuis PT, Sharp V, Cohn J, Wilson I, et al. Differences in patient–provider communication for Hispanic compared to non-Hispanic white patients in HIV care. J Gen Intern Med. 2010;25(7):682–7.CrossRefPubMedPubMedCentral
25.
go back to reference Beach MC, Roter D, Korthuis PT, Epstein RM, Sharp V, Ratanawongsa N, et al. A multicenter study of physician mindfulness and health care quality. Ann Fam Med. 2013;11(5):421–8.CrossRefPubMedPubMedCentral Beach MC, Roter D, Korthuis PT, Epstein RM, Sharp V, Ratanawongsa N, et al. A multicenter study of physician mindfulness and health care quality. Ann Fam Med. 2013;11(5):421–8.CrossRefPubMedPubMedCentral
26.
go back to reference Saha S, Korthuis PT, Cohn JA, Sharp VL, Moore RD, Beach MC. Primary care provider cultural competence and racial disparities in HIV care and outcomes. J Gen Intern Med. 2013;28(5):622–9.CrossRefPubMedPubMedCentral Saha S, Korthuis PT, Cohn JA, Sharp VL, Moore RD, Beach MC. Primary care provider cultural competence and racial disparities in HIV care and outcomes. J Gen Intern Med. 2013;28(5):622–9.CrossRefPubMedPubMedCentral
27.
go back to reference Korthuis PT, Saha S, Chander G, McCarty D, Moore RD, Cohn JA, et al. Substance use and the quality of patient–provider communication in HIV clinics. AIDS Behav. 2011;15(4):832–41.CrossRefPubMedPubMedCentral Korthuis PT, Saha S, Chander G, McCarty D, Moore RD, Cohn JA, et al. Substance use and the quality of patient–provider communication in HIV clinics. AIDS Behav. 2011;15(4):832–41.CrossRefPubMedPubMedCentral
28.
go back to reference Beach MC, Roter DL, Saha S, Korthuis PT, Eggly S, Cohn J, et al. Impact of a brief patient and provider intervention to improve the quality of communication about medication adherence among HIV patients. Patient Educ Couns. 2015;98(9):1078–83.CrossRefPubMedPubMedCentral Beach MC, Roter DL, Saha S, Korthuis PT, Eggly S, Cohn J, et al. Impact of a brief patient and provider intervention to improve the quality of communication about medication adherence among HIV patients. Patient Educ Couns. 2015;98(9):1078–83.CrossRefPubMedPubMedCentral
29.
go back to reference McLellan AT, Luborsky L, Woody GE, O’Brien CP. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis. 1980;168(1):26–33.CrossRefPubMed McLellan AT, Luborsky L, Woody GE, O’Brien CP. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis. 1980;168(1):26–33.CrossRefPubMed
30.
go back to reference Cacciola JS, Alterman AI, McLellan AT, Lin Y-T, Lynch KG. Initial evidence for the reliability and validity of a “Lite” version of the Addiction Severity Index. Drug Alcohol Depend. 2007;87(2–3):297–302.CrossRefPubMed Cacciola JS, Alterman AI, McLellan AT, Lin Y-T, Lynch KG. Initial evidence for the reliability and validity of a “Lite” version of the Addiction Severity Index. Drug Alcohol Depend. 2007;87(2–3):297–302.CrossRefPubMed
31.
go back to reference Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption—II. Addict Abingdon Engl. 1993;88(6):791–804.CrossRef Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption—II. Addict Abingdon Engl. 1993;88(6):791–804.CrossRef
32.
go back to reference Peräkylä A. Conversation analysis: a new model of research in doctor-patient communication. J R Soc Med. 1997;90(4):205–8.PubMedPubMedCentral Peräkylä A. Conversation analysis: a new model of research in doctor-patient communication. J R Soc Med. 1997;90(4):205–8.PubMedPubMedCentral
33.
go back to reference Drew P, Chatwin J, Collins S. Conversation analysis: a method for research into interactions between patients and health-care professionals. Health Expect Int J Public Particip Health Care Health Policy. 2001;4(1):58–70. Drew P, Chatwin J, Collins S. Conversation analysis: a method for research into interactions between patients and health-care professionals. Health Expect Int J Public Particip Health Care Health Policy. 2001;4(1):58–70.
34.
go back to reference Bradburn NM, Sudman S, Blair E, Stocking C. Question threat and response bias. Public Opin Q. 1978;42(2):221–34.CrossRef Bradburn NM, Sudman S, Blair E, Stocking C. Question threat and response bias. Public Opin Q. 1978;42(2):221–34.CrossRef
35.
go back to reference Ray MK, Beach MC, Nicolaidis C, Choi D, Saha S, Korthuis PT. Patient and provider comfort discussing substance use. Fam Med. 2013;45(2):109–17.PubMedPubMedCentral Ray MK, Beach MC, Nicolaidis C, Choi D, Saha S, Korthuis PT. Patient and provider comfort discussing substance use. Fam Med. 2013;45(2):109–17.PubMedPubMedCentral
36.
go back to reference Callon W, Saha S, Korthuis PT, Wilson IB, Moore RD, Cohn J, et al. Which Clinician Questions Elicit Accurate Disclosure of Antiretroviral Non-adherence When Talking to Patients? AIDS Behav. 2015 Oct 26;1–8. Callon W, Saha S, Korthuis PT, Wilson IB, Moore RD, Cohn J, et al. Which Clinician Questions Elicit Accurate Disclosure of Antiretroviral Non-adherence When Talking to Patients? AIDS Behav. 2015 Oct 26;1–8.
37.
go back to reference Kelly JF, Wakeman SE, Saitz R. Stop talking “dirty”: clinicians, language, and quality of care for the leading cause of preventable death in the United States. Am J Med. 2015;128(1):8–9.CrossRefPubMed Kelly JF, Wakeman SE, Saitz R. Stop talking “dirty”: clinicians, language, and quality of care for the leading cause of preventable death in the United States. Am J Med. 2015;128(1):8–9.CrossRefPubMed
38.
go back to reference Staines GL, Magura S, Foote J, Deluca A, Kosanke N. Polysubstance use among alcoholics. J Addict Dis. 2001;20(4):53–69.CrossRefPubMed Staines GL, Magura S, Foote J, Deluca A, Kosanke N. Polysubstance use among alcoholics. J Addict Dis. 2001;20(4):53–69.CrossRefPubMed
39.
go back to reference Leri F, Bruneau J, Stewart J. Understanding polydrug use: review of heroin and cocaine co-use. Addiction. 2003;98(1):7–22.CrossRefPubMed Leri F, Bruneau J, Stewart J. Understanding polydrug use: review of heroin and cocaine co-use. Addiction. 2003;98(1):7–22.CrossRefPubMed
40.
go back to reference Conway KP, Kane RJ, Ball SA, Poling JC, Rounsaville BJ. Personality, substance of choice, and polysubstance involvement among substance dependent patients. Drug Alcohol Depend. 2003;71(1):65–75.CrossRefPubMed Conway KP, Kane RJ, Ball SA, Poling JC, Rounsaville BJ. Personality, substance of choice, and polysubstance involvement among substance dependent patients. Drug Alcohol Depend. 2003;71(1):65–75.CrossRefPubMed
41.
go back to reference Ekholm O, Strandberg-Larsen K, Christensen K, Grønbaek M. Comparison of assessment methods for self-reported alcohol consumption in health interview surveys. Eur J Clin Nutr. 2008;62(2):286–91.CrossRefPubMed Ekholm O, Strandberg-Larsen K, Christensen K, Grønbaek M. Comparison of assessment methods for self-reported alcohol consumption in health interview surveys. Eur J Clin Nutr. 2008;62(2):286–91.CrossRefPubMed
42.
go back to reference Gmel G, Lokosha O. Self-reported frequency of drinking assessed with a closed- or open-ended question format: a split-sample study in Switzerland. J Stud Alcohol. 2000;61(3):450–4.CrossRefPubMed Gmel G, Lokosha O. Self-reported frequency of drinking assessed with a closed- or open-ended question format: a split-sample study in Switzerland. J Stud Alcohol. 2000;61(3):450–4.CrossRefPubMed
43.
go back to reference Ivis FJ, Bondy SJ, Adlaf EM. The effect of question structure on self-reports of heavy drinking: closed-ended versus open-ended questions. J Stud Alcohol. 1997;58(6):622–4.CrossRefPubMed Ivis FJ, Bondy SJ, Adlaf EM. The effect of question structure on self-reports of heavy drinking: closed-ended versus open-ended questions. J Stud Alcohol. 1997;58(6):622–4.CrossRefPubMed
44.
go back to reference Blair E, Sudman S, Bradburn NM, Stocking C. How to Ask Questions about Drinking and Sex: Response Effects in Measuring Consumer Behavior. J Mark Res. 1977;14(3):316–21.CrossRef Blair E, Sudman S, Bradburn NM, Stocking C. How to Ask Questions about Drinking and Sex: Response Effects in Measuring Consumer Behavior. J Mark Res. 1977;14(3):316–21.CrossRef
45.
go back to reference Wolraich ML, Albanese M, Stone G, Nesbitt D, Thomson E, Shymansky J, et al. Medical Communication Behavior System. An interactional analysis system for medical interactions. Med Care. 1986;24(10):891–903.CrossRefPubMed Wolraich ML, Albanese M, Stone G, Nesbitt D, Thomson E, Shymansky J, et al. Medical Communication Behavior System. An interactional analysis system for medical interactions. Med Care. 1986;24(10):891–903.CrossRefPubMed
46.
go back to reference Pringle M, Stewart-Evans C. Does awareness of being video recorded affect doctors’ consultation behaviour? Br J Gen Pract. 1990;40(340):455–8.PubMedPubMedCentral Pringle M, Stewart-Evans C. Does awareness of being video recorded affect doctors’ consultation behaviour? Br J Gen Pract. 1990;40(340):455–8.PubMedPubMedCentral
47.
go back to reference Penner LA, Orom H, Albrecht TL, Franks MM, Foster TS, Ruckdeschel JC. Camera-related behaviors during video recorded medical interactions. J Nonverbal Behav. 2007;31(2):99–117.CrossRef Penner LA, Orom H, Albrecht TL, Franks MM, Foster TS, Ruckdeschel JC. Camera-related behaviors during video recorded medical interactions. J Nonverbal Behav. 2007;31(2):99–117.CrossRef
Metadata
Title
Assessing Problematic Substance Use in HIV Care: Which Questions Elicit Accurate Patient Disclosures?
Authors
Wynne Callon, BA
Mary Catherine Beach, MD, MPH
Somnath Saha, MD, MPH
Geetanjali Chander, MD, MPH
Ira B. Wilson, MD
Michael Barton Laws, PhD
Victoria Sharp, MD
Jonathan Cohn, MD
Richard Moore, MD, MHS
P. Todd Korthuis, MD, MPH
Publication date
01-10-2016
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 10/2016
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-016-3733-z

Other articles of this Issue 10/2016

Journal of General Internal Medicine 10/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.